<http://schema.org/description>
"Researchers at Mount Sinai School of Medicine have found in a Phase II trial that a gene therapy developed at Mount Sinai stabilized or improved cardiac function in people with severe heart failure. Patients receiving a high dose of the therapy, called SERCA2a, experienced substantial clinical benefit and significantly reduced cardiovascular hospitalizations, addressing a critical unmet need in this population. The data are published online in the June 27 issue of the American Heart Association journal Circulation."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2011-06-gene-therapy-heart-failure.html>